TW200513462A - Stable polymorph of bifeprunox mesilate (7-[4-([1,1'-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate) - Google Patents

Stable polymorph of bifeprunox mesilate (7-[4-([1,1'-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)

Info

Publication number
TW200513462A
TW200513462A TW093124532A TW93124532A TW200513462A TW 200513462 A TW200513462 A TW 200513462A TW 093124532 A TW093124532 A TW 093124532A TW 93124532 A TW93124532 A TW 93124532A TW 200513462 A TW200513462 A TW 200513462A
Authority
TW
Taiwan
Prior art keywords
ylmethyl
piperazinyl
biphenyl
stable polymorph
bifeprunox
Prior art date
Application number
TW093124532A
Other languages
English (en)
Other versions
TWI336695B (en
Inventor
Klaas Zwier
Gerrit Klein
Irene Eijgendaal
Horst-Van Amstel Maria J L Ter
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34924088&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200513462(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of TW200513462A publication Critical patent/TW200513462A/zh
Application granted granted Critical
Publication of TWI336695B publication Critical patent/TWI336695B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
TW093124532A 2003-08-18 2004-08-16 Stable polymorph of bifeprunox mesilate (7-[4-([1,1'-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3h)-benzoxazolone monomethanesulfonate) TWI336695B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03102573 2003-08-18

Publications (2)

Publication Number Publication Date
TW200513462A true TW200513462A (en) 2005-04-16
TWI336695B TWI336695B (en) 2011-02-01

Family

ID=34924088

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093124532A TWI336695B (en) 2003-08-18 2004-08-16 Stable polymorph of bifeprunox mesilate (7-[4-([1,1'-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3h)-benzoxazolone monomethanesulfonate)

Country Status (26)

Country Link
EP (1) EP1656358B1 (zh)
JP (1) JP2007502802A (zh)
CN (1) CN100422159C (zh)
AR (1) AR045362A1 (zh)
AT (1) ATE499348T1 (zh)
AU (1) AU2004265104B2 (zh)
BR (1) BRPI0413617A (zh)
CA (1) CA2536149C (zh)
DE (1) DE602004031534D1 (zh)
DK (1) DK1656358T3 (zh)
EA (1) EA008182B1 (zh)
ES (1) ES2361508T3 (zh)
IS (1) IS8279A (zh)
ME (1) MEP37108A (zh)
MX (1) MXPA06001881A (zh)
MY (1) MY139462A (zh)
NO (1) NO20061265L (zh)
NZ (1) NZ545415A (zh)
PL (1) PL1656358T3 (zh)
PT (1) PT1656358E (zh)
RS (1) RS20060113A (zh)
SI (1) SI1656358T1 (zh)
TW (1) TWI336695B (zh)
UA (1) UA85562C2 (zh)
WO (1) WO2005016898A2 (zh)
ZA (1) ZA200601399B (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7423040B2 (en) * 2005-02-18 2008-09-09 Irene Eijgendaal Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using same
JP2009539942A (ja) * 2006-06-16 2009-11-19 ソルベイ・フアーマシユーチカルズ・ベー・ブイ ビフェプルノックス及びｌ−ｄｏｐａを含む組み合わせ製剤
WO2008025780A1 (en) * 2006-08-31 2008-03-06 Solvay Pharmaceuticals B.V. Titration schedule for bifeprunox for treating schizophrenia and kits for use therein
WO2011023796A1 (en) 2009-08-31 2011-03-03 Abbott Healthcare Products B.V. Bifeprunox for treating addiction
US9675101B2 (en) 2013-03-15 2017-06-13 Whirlpool Corporation High performance adjustable juicer with whole foods feed chute
US9556916B2 (en) 2013-03-15 2017-01-31 Whirlpool Corporation High performance adjustable juicer with whole foods feed chute and clutch mechanism

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0889889B1 (en) * 1996-03-29 2006-09-20 Duphar International Research B.V Piperazine and piperidine compounds
IL127497A (en) * 1997-12-18 2002-07-25 Pfizer Prod Inc Medicinal products containing piperazinyl-heterocyclic compounds for the treatment of psychiatric disorders
AU2003999A (en) * 1997-12-19 1999-07-12 Advanced Research And Technology Institute, Inc. Modulators of ryanodine receptors comprising 2-(aryl)-4,7-dioxobenzothiazoles and analogues thereof
AR034206A1 (es) * 2001-02-16 2004-02-04 Solvay Pharm Bv Un procedimiento para la preparacion de mesilatos de derivados de piperazina y dichos mesilatos

Also Published As

Publication number Publication date
ATE499348T1 (de) 2011-03-15
DK1656358T3 (da) 2011-05-30
UA85562C2 (en) 2009-02-10
ZA200601399B (en) 2007-04-25
TWI336695B (en) 2011-02-01
WO2005016898B1 (en) 2005-05-19
WO2005016898A3 (en) 2005-04-07
MXPA06001881A (es) 2006-05-17
WO2005016898A2 (en) 2005-02-24
AU2004265104B2 (en) 2009-06-04
EP1656358A2 (en) 2006-05-17
PT1656358E (pt) 2011-05-12
MEP37108A (en) 2011-02-10
EP1656358B1 (en) 2011-02-23
ES2361508T3 (es) 2011-06-17
PL1656358T3 (pl) 2011-07-29
RS20060113A (en) 2008-09-29
NO20061265L (no) 2006-05-09
SI1656358T1 (sl) 2011-06-30
CN100422159C (zh) 2008-10-01
BRPI0413617A (pt) 2006-10-17
CN1835935A (zh) 2006-09-20
NZ545415A (en) 2009-11-27
EA200600442A1 (ru) 2006-08-25
AU2004265104A1 (en) 2005-02-24
MY139462A (en) 2009-10-30
IS8279A (is) 2006-01-31
DE602004031534D1 (de) 2011-04-07
CA2536149C (en) 2011-03-22
AR045362A1 (es) 2005-10-26
EA008182B1 (ru) 2007-04-27
CA2536149A1 (en) 2005-02-24
JP2007502802A (ja) 2007-02-15

Similar Documents

Publication Publication Date Title
WO2003004480A3 (en) Substituted piperazine and diazepanes as histamine h3 receptor agonists
EP1797878A3 (en) Benzothiazole derivatives
TW200621762A (en) Novel compounds
MX2008013836A (es) Derivados de 2-piridona para el tratamiento de enfermedades o condiciones en las cuales es benefica la inhibicion de la actividad de elastasa de neutrofilos.
IL188942A0 (en) Benzimidazole derivatives and pharmaceutical compositions containing the same
MXPA06001838A (es) Sales de succinato y malonato de la trans-4- ((ir, 3s)-6 -cloro-3- fenilindan -1-il)-1, 2, 2- trimetilpiperazina y su uso como medicamento.
NO20084853L (no) Forbindelser som er agonister av muscarinreseptorer og som kan vaere effektive i behandling av smerte, Alzheimers sykdom og/eller schizofreni
SG170101A1 (en) 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial.
WO2007046868A3 (en) Thiazolidine derivatives and their uses as therapeutic agents
MXPA04002338A (es) Derivados de carbazol y su uso como antagonistas receptores del npy5.
WO2002080846A3 (en) Epothilone derivatives and methods for making and using the same
DE602004014163D1 (de) Pyrimidylpyrrolderivate, die als kinaseinhibitoren wirken
PL1853232T3 (pl) Trwałe postaci krystaliczne mesylanu bifeprunoksu, postaci dawkowania oraz sposoby ich stosowania
WO2006125194A3 (en) Piperazine derivatives and their uses as therapeutic agents
NO20061265L (no) Stabil krystallinsk form av bifeprunoksmesylat (7-[4-([l,l-bifenyl]-3-yl-metyl)-1-piperazinyl]-2(3H)-benzokazolon monometansulfona
AU2005313582A8 (en) Malonamide derivatives as inhibitors of gamma-secretase for the treatment of Alzheimer's disease
EP1817311A4 (en) 2,3,4,6-SUBSTITUTED PYRIDYL DERIVATIVE COMPOUNDS AS BETA SEKTRETASE INHIBITORS FOR THE TREATMENT OF MORBUS ALZHEIMER
PL1631296T3 (pl) Pochodne amidu kwasu 2,3,4,5,-tetrahydrobenzo[f][1,4]oksazepino-5-karboksylowego jako inhibitory gamma-sekretazy do leczenia choroby Alzheimera
NO20052699L (no) 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser.
PL1727817T3 (pl) Pochodne azabicyklooktan-3-onu i ich zastosowanie
AU2003232805A1 (en) Pharmaceutical active substance combination and the use thereof
AR037711A1 (es) Sal de acido citrico de un compuesto terapeutico y composiciones farmaceuticas que la contienen
HUP0401115A3 (en) 4-(benzylideneamino)-3-(methylsulfanyl)-4h-[1,2,4]triazin-5-one derivatives having a pde iv-inhibiting and tnf-antagonistic action for the treatment of heart diseases and allergies, process for their preparation and pharmaceutical compositions ...
IL173294A (en) A crystalline polymorph of (7 - [4 - ([1,1'- biphenyl] - 3 - ylmethyl) - 1 - piperazinyl] - 2 (3h) - benzoxazolone monomethanesulfonate, process for its preparation and pharmaceutical compositions comprising it
UA92463C2 (ru) Производные пиримидинсульфонамида как модуляторы рецепторов хемокина

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees